IP Library Assignment 063008/0512
Patent Assignment
Reel/Frame 063008/0512

Assignment of Assignor's Interest

Recorded: 2023-03-16 Pages: 3
Assignor
ROBERTS, MARY SCOTT
Executed: 2021-09-13
Assignee
BRIDGEBIO SERVICES INC.
421 KIPLING STREET, PALO ALTO, CALIFORNIA, 94301
Covered Property (1)
Treatment Methods of Triphenyl Calcilytic Compounds
Application: 17/477,198 →
Publication: US 2022/0087961
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 8, 2023
From: COLLINS, MICHAEL T.; GAFNI, RACHEL I.; ROSZKO, KELLY B.L.; HARTLEY, IRIS R.
To: UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 062924/0979 →
Assignment of Assignor's Interest Mar 16, 2023
From: BRIDGEBIO SERVICES INC.
To: CALCILYTIX THERAPEUTICS, INC.
Reel/Frame 063008/0548 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →